Sat Kartar Life

Which are the latest news on Sat Kartar Life?

Why is Sat Kartar Life Ltd falling/rising?

As of 05-Sep, Sat Kartar Life Ltd's stock price is Rs 116.70, down 1.27%, and has significantly underperformed with an 18.39% year-to-date decline compared to the Sensex. The stock is trading below its moving averages and is near its 52-week low, indicating a bearish trend.

As of 05-Sep, Sat Kartar Life Ltd's stock price is falling, currently at Rs 116.70, which reflects a decrease of Rs 1.5 or 1.27%. The stock has underperformed significantly over various time periods, with a year-to-date decline of 18.39% compared to a 8.54% drop in the benchmark Sensex. Over the past year, the stock has decreased by 30.62%, while the Sensex has only fallen by 3.38%. <BR><BR>Additionally, the stock is trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. It is also close to its 52-week low, being only 4.03% away from Rs 112. Despite a rise in investor participation, with a 22.7% increase in delivery volume on September 3rd, the overall performance today shows that it has underperformed its sector by 0.82%. These factors collectively contribute to the ongoing decline in the stock's price.

What does Sat Kartar Life do?

Sat Kartar Life Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, incorporated in 2012 and converted to a Public Limited Company in 2021. It currently has no available sales or profit data, with a market cap of INR 217 Cr and a P/E ratio of 11.00.

Overview:<BR>Sat Kartar Life Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>Sat Kartar Life Ltd was incorporated in 2012 as a Private Limited Company under the name "Sat Kartar Shopping Private Limited." The company later converted to a Public Limited Company and changed its name to Sat Kartar Shopping Limited in July 2021. There is no sales or profit data available for the latest quarter.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 217 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 11.00<BR>Industry P/E: 37<BR>Dividend Yield: 0.50%<BR>Debt-Equity: -0.28<BR>Return on Equity: 25.51%<BR>Price-to-Book: 3.25<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Who are the peers of the Sat Kartar Life?

Sat Kartar Life's peers include Natural Capsules, Accretion Pha., Brooks Lab., Oxygenta Pharma, Sanjiv.Parant., CCME Global, and Coral Labs. Among these, Accretion Pha. shows the best performance in management risk, growth, and returns, while Brooks Lab. has the lowest 1-year return.

Peers: The peers of Sat Kartar Life are Natural Capsules, Accretion Pha., Brooks Lab., Oxygenta Pharma, Sanjiv.Parant., CCME Global, and Coral Labs.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sat Kartar Life, while Good management risk is found at Accretion Pha. and Sanjiv.Parant., and Below Average management risk is noted at Natural Capsules, Brooks Lab., CCME Global, and Coral Labs. Excellent growth is seen at Accretion Pha. and Sat Kartar Life, while Good growth is present at Sanjiv.Parant., and Below Average growth is noted at Natural Capsules, Brooks Lab., and CCME Global. Excellent capital structure is observed at Sat Kartar Life and Sanjiv.Parant., while Good capital structure is found at Accretion Pha., and Below Average capital structure is noted at Natural Capsules, Brooks Lab., Oxygenta Pharma, CCME Global, and Coral Labs.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Accretion Pha. with a return of N/A, while Brooks Lab. has the lowest 1-year return at -50.60%, and Sat Kartar Life's 1-year return of -26.77% is better than Brooks Lab.'s but worse than Accretion Pha.'s. Additionally, Natural Capsules, Brooks Lab., and Sat Kartar Life have negative six-month returns.

How big is Sat Kartar?

As of 10th June, Sat Kartar Shopping Ltd has a market capitalization of 252.00 Cr, classifying it as a Micro Cap company, with no valid financial data available for Net Sales and Net Profit for the latest four quarters. The balance sheet as of March 2025 shows Shareholder's Funds of 51.50 Cr and Total Assets of 63.03 Cr.

As of 10th June, <BR><BR>Market Cap: Sat Kartar Shopping Ltd has a market capitalization of 252.00 Cr, classifying it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 51.50 Cr and Total Assets of 63.03 Cr.

Is Sat Kartar overvalued or undervalued?

As of October 7, 2025, Sat Kartar is considered fairly valued with a PE ratio of 24.36, an EV to EBITDA of 15.07, and a ROE of 19.07%, making it an attractive investment compared to peers despite a recent 1-month return of -9.55%.

As of 7 October 2025, the valuation grade for Sat Kartar has moved from very attractive to attractive, indicating a shift in market perception. The company is currently considered fairly valued. Key ratios include a PE ratio of 24.36, an EV to EBITDA of 15.07, and a ROE of 19.07%. <BR><BR>In comparison to peers, Sat Kartar's PE ratio is lower than Sun Pharma's 34.6 and Divi's Lab's 70.24, which are considered expensive, while it is higher than Cipla's 22.68 and Dr. Reddy's Labs' 18.37, both of which are attractive. Despite the recent underperformance with a 1-month return of -9.55% compared to the Sensex's 1.48%, the company's strong fundamentals suggest it remains a solid investment within the pharmaceuticals and biotechnology sector.

How has been the historical performance of the Sat Kartar?

Sat Kartar reported a profit before tax of Rs 8.00 crore for the year ending March 2024, with a net cash inflow of Rs 1.00 crore, resulting in a closing cash balance of Rs 2.00 crore despite cash outflows from investing and financing activities.

Answer:<BR>The historical performance of Sat Kartar shows a profit before tax of Rs 8.00 crore for the year ending March 2024. After accounting for adjustments of Rs 1.00 crore, the cash flow after changes in working capital stands at Rs 10.00 crore. The cash flow from operating activities is recorded at Rs 7.00 crore, while cash flow from investing and financing activities both show outflows of Rs 2.00 crore each. This results in a net cash inflow of Rs 1.00 crore, leading to a closing cash and cash equivalent balance of Rs 2.00 crore.<BR><BR>Breakdown:<BR>In the standalone cash flow results for March 2024, Sat Kartar reported a profit before tax of Rs 8.00 crore, with adjustments bringing the cash flow after changes in working capital to Rs 10.00 crore. The cash flow from operating activities was positive at Rs 7.00 crore, indicating healthy operational performance. However, the company experienced cash outflows from both investing and financing activities, each amounting to Rs 2.00 crore. Despite these outflows, Sat Kartar achieved a net cash inflow of Rs 1.00 crore, resulting in a closing cash and cash equivalent balance of Rs 2.00 crore, reflecting a modest liquidity position.

Who are the top shareholders of the Sat Kartar?

The top shareholders of Sat Kartar include Ajooni Wellness Private Limited with 36.28%, eight Foreign Institutional Investors holding 6.31%, and Shreya Jain as the highest public shareholder at 3.56%. Individual investors own 17.81% of the shares, with no pledged promoter holdings or mutual fund investments.

The top shareholders of Sat Kartar include Ajooni Wellness Private Limited, which holds the highest stake at 36.28%. Additionally, there are eight Foreign Institutional Investors (FIIs) collectively holding 6.31% of the company. The highest public shareholder is Shreya Jain, with a holding of 3.56%. Individual investors collectively own 17.81% of the shares. There are no pledged promoter holdings, and no mutual funds are currently holding shares in the company.

When is the next results date for Sat Kartar?

No Upcoming Board Meetings

Has Sat Kartar declared dividend?

No Dividend History Available